1. Home
  2. ANL vs SVC Comparison

ANL vs SVC Comparison

Compare ANL & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

BUY

Current Price

$10.74

Market Cap

998.8M

Sector

N/A

ML Signal

BUY

SVC

Service Properties Trust

HOLD

Current Price

$6.19

Market Cap

839.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANL
SVC
Founded
2004
1995
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
998.8M
839.2M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
ANL
SVC
Price
$10.74
$6.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
★ $29.50
$12.19
AVG Volume (30 Days)
310.2K
★ 2.4M
Earning Date
08-14-2026
11-04-2026
Dividend Yield
N/A
★ 3.28%
EPS Growth
N/A
★ 26.95
EPS
★ N/A
N/A
Revenue
N/A
★ $1,814,838,000.00
Revenue This Year
$243.83
N/A
Revenue Next Year
N/A
$3.31
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.88
$1.13
52 Week High
$17.25
$9.02

Technical Indicators

Market Signals
Indicator
ANL
SVC
Relative Strength Index (RSI) 36.09 45.70
Support Level $8.96 $5.65
Resistance Level $12.49 $6.87
Average True Range (ATR) 1.45 0.49
MACD -0.40 0.02
Stochastic Oscillator 5.63 24.07

Price Performance

Historical Comparison
ANL
SVC

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.

Share on Social Networks: